Cancer vaccine development: protein transfer of membrane-anchored cytokines and immunostimulatory molecules (Q35794652)

10 August 2017

1 reference

title

Cancer vaccine development: protein transfer of membrane-anchored cytokines and immunostimulatory molecules (English)

1 reference

10 August 2017

Ashley M Cimino

1

1 reference

10 August 2017

Purani Palaniswami

series ordinal

2

1 reference

10 August 2017

Andrew C Kim

series ordinal

3

1 reference

10 August 2017

Periasamy Selvaraj

series ordinal

4

1 reference

10 August 2017

1 January 2004

1 reference

10 August 2017

1 reference

10 August 2017

29

1 reference

10 August 2017

1-3

1 reference

10 August 2017

231-240

1 reference

https://scigraph.springernature.com/pub.10.1385/ir:29:1-3:231

10 August 2017

0 references

cites work

Specificity and longevity of antitumor immune responses induced by B7-transfected tumors

1 reference

12 December 2020

Glycosylphosphatidylinositol-anchored CD4/Thy-1 chimeric molecules serve as human immunodeficiency virus receptors in human, but not mouse, cells and are modulated by gangliosides.

1 reference

12 December 2020

Specific T cell recognition of peptides derived from prostate-specific antigen in patients with prostate cancer

1 reference

12 December 2020

Binding of the B cell activation antigen B7 to CD28 costimulates T cell proliferation and interleukin 2 mRNA accumulation

1 reference

12 December 2020

B7-1/CD80-transduced tumor cells elicit better systemic immunity than wild-type tumor cells admixed with Corynebacterium parvum

1 reference

12 December 2020

CD28-mediated signalling co-stimulates murine T cells and prevents induction of anergy in T-cell clones

1 reference

12 December 2020

Immune and clinical responses in patients with metastatic melanoma to CD34(+) progenitor-derived dendritic cell vaccine

1 reference

12 December 2020

Constitutive expression of B7 restores immunogenicity of tumor cells expressing truncated major histocompatibility complex class II molecules

1 reference

12 December 2020

Cytokine-secreting tumor cell vaccines

1 reference

12 December 2020

Anti-metastatic vaccination of tumor-bearing mice with IL-2-gene-inserted tumor cells

1 reference

12 December 2020

Effects of single-dose interleukin-12 exposure on interleukin-12-associated toxicity and interferon-gamma production

1 reference

12 December 2020

ITAMs versus ITIMs: striking a balance during cell regulation

1 reference

12 December 2020

Processing and presentation of antigens by dendritic cells: implications for vaccines

1 reference

12 December 2020

Glycosylphosphatidylinositol-modified murine B7-1 and B7-2 retain costimulator function

1 reference

12 December 2020

Immunization with granulocyte-macrophage colony-stimulating factor-transduced, but not B7-1-transduced, lymphoma cells primes idiotype-specific T cells and generates potent systemic antitumor immunity

1 reference

12 December 2020

Interleukin-12 (IL-12) alone or in synergistic combination with IL-2 for in vitro activation of human bone marrow: differential effects at different time points

1 reference

12 December 2020

Lymphokine-activated killer cells: a new approach to immunotherapy of cancer

1 reference

12 December 2020

Impact of cytokine administration on the generation of antitumor reactivity in patients with metastatic melanoma receiving a peptide vaccine

1 reference

12 December 2020

Development of therapeutic vaccines by direct modification of cell membranes from surgically removed human tumor tissue with immunostimulatory molecules

1 reference

12 December 2020

Interleukin-12 and B7.1 co-stimulation cooperate in the induction of effective antitumor immunity and therapy of established tumors.

1 reference

12 December 2020

Expression of functional IL-2 receptors on mature splenic dendritic cells

1 reference

12 December 2020

Eliciting T cell immunity against poorly immunogenic tumors by immunization with dendritic cell-tumor fusion vaccines

1 reference

12 December 2020

Alloantigenic recognition of artificial glycosyl phosphatidylinositol-anchored HLA-A2.1.

1 reference

12 December 2020

Transduction of a foreign histocompatibility gene into the arterial wall induces vasculitis

1 reference

12 December 2020

Adoptive Immunotherapy of Established Pulmonary Metastases with LAK Cells and Recombinant Interleukin-2

1 reference

12 December 2020

Interleukin-2 toxicity

1 reference

12 December 2020

Identification of HLA-A3-restricted cytotoxic T lymphocyte epitopes from carcinoembryonic antigen and HER-2/neu by primary in vitro immunization with peptide-pulsed dendritic cells

1 reference

12 December 2020

Glycolipid-anchored IL-12 expressed on tumor cell surface induces antitumor immune response

1 reference

12 December 2020

GPI-anchoring of GM-CSF results in active membrane-bound and partially shed cytokine

1 reference

12 December 2020

Biological properties and therapeutic applications of interleukin-12.

1 reference

12 December 2020

CD28 interaction with B7 costimulates primary allogeneic proliferative responses and cytotoxicity mediated by small, resting T lymphocytes

1 reference

12 December 2020

Induction of autologous tumor-specific cytotoxic T-lymphocyte activity against a human renal carcinoma cell line by B7-1 (CD8O) costimulation

1 reference

12 December 2020

Costimulation of tumor-reactive CD4+ and CD8+ T lymphocytes by B7, a natural ligand for CD28, can be used to treat established mouse melanoma

1 reference

12 December 2020

Vaccination with irradiated tumor cells engineered to secrete murine granulocyte-macrophage colony-stimulating factor stimulates potent, specific, and long-lasting anti-tumor immunity

1 reference

12 December 2020

Spontaneous incorporation of the glycosyl-phosphatidylinositol-linked protein Thy-1 into cell membranes

1 reference

12 December 2020

Human immunodeficiency virus infection is efficiently mediated by a glycolipid-anchored form of CD4.

1 reference

12 December 2020

Cell-surface anchoring of proteins via glycosyl-phosphatidylinositol structures

1 reference

12 December 2020

Clonal analysis of cytotoxic T cell response against human melanoma

1 reference

12 December 2020

Paracrine cytokine adjuvants in cancer immunotherapy

1 reference

12 December 2020

Inhibition of complement activation on the surface of cells after incorporation of decay-accelerating factor (DAF) into their membranes

1 reference

12 December 2020

Engrafting costimulator molecules onto tumor cell surfaces with chelator lipids: a potentially convenient approach in cancer vaccine development

1 reference

12 December 2020

In vivo administration of purified human interleukin 2. II. Half life, immunologic effects, and expansion of peripheral lymphoid cells in vivo with recombinant IL 2.

1 reference

12 December 2020

Construction, purification, and functional incorporation on tumor cells of glycolipid-anchored human B7-1 (CD80).

1 reference

12 December 2020

Antitumor and antimetastatic activity of interleukin 12 against murine tumors

1 reference

12 December 2020

Effective tumor vaccine generated by fusion of hepatoma cells with activated B cells

1 reference

12 December 2020

Use of tumor-infiltrating lymphocytes and interleukin-2 in the immunotherapy of patients with metastatic melanoma. A preliminary report

1 reference

12 December 2020

Induction of alloantigen-specific hyporesponsiveness in human T lymphocytes by blocking interaction of CD28 with its natural ligand B7/BB1

1 reference

12 December 2020

Major histocompatibility complex class II+B7-1+ tumor cells are potent vaccines for stimulating tumor rejection in tumor-bearing mice

1 reference

12 December 2020

Dendritic cell-dead cell interactions: implications and relevance for immunotherapy.

1 reference

12 December 2020

Clonal expansion versus functional clonal inactivation: a costimulatory signalling pathway determines the outcome of T cell antigen receptor occupancy

1 reference

12 December 2020

Effect of human recombinant IL-2 on murine macrophage precursors. Involvement of a receptor distinct from the p55 (Tac) protein

1 reference

12 December 2020

Human T-cell clonal anergy is induced by antigen presentation in the absence of B7 costimulation

1 reference

12 December 2020

Identification of potential CTL epitopes of tumor-associated antigen MAGE-1 for five common HLA-A alleles

1 reference

12 December 2020

Current approaches to the adoptive immunotherapy of cancer

1 reference

12 December 2020

The role of CD4+ T cell responses in antitumor immunity

1 reference

12 December 2020

Reduction of established spontaneous mammary carcinoma metastases following immunotherapy with major histocompatibility complex class II and B7.1 cell-based tumor vaccines.

1 reference

12 December 2020

Heat shock proteins come of age: primitive functions acquire new roles in an adaptive world.

1 reference

12 December 2020

Two types of murine helper T cell clone. I. Definition according to profiles of lymphokine activities and secreted proteins

1 reference

12 December 2020

Analysis of the effect of cytokines (interleukins 2, 3, 4, and 6, granulocyte-monocyte colony-stimulating factor, and interferon-gamma) on generation of primary cytotoxic T lymphocytes against a weakly immunogenic tumor

1 reference

12 December 2020

Biology of natural killer cells

1 reference

12 December 2020

Bioactivity of autologous irradiated renal cell carcinoma vaccines generated by ex vivo granulocyte-macrophage colony-stimulating factor gene transfer

1 reference

12 December 2020

Plasmid DNA is superior to viral vectors for direct gene transfer into adult mouse skeletal muscle

1 reference

12 December 2020

Bone marrow-derived dendritic cells pulsed with synthetic tumour peptides elicit protective and therapeutic antitumour immunity

1 reference

12 December 2020

Cutting edge: tumor secreted heat shock-fusion protein elicits CD8 cells for rejection.

1 reference

12 December 2020

The central role of CD4(+) T cells in the antitumor immune response

1 reference

12 December 2020

Dendritic cells and the control of immunity

1 reference

12 December 2020

Interleukin-12: basic principles and clinical applications.

1 reference

12 December 2020

Antitumor response elicited by a superantigen-transmembrane sequence fusion protein anchored onto tumor cells

1 reference

12 December 2020

Purification and optimization of functional reconstitution on the surface of leukemic cell lines of GPI-anchored Fc gamma receptor III

1 reference

12 December 2020

Structural and functional roles of glycosyl-phosphatidylinositol in membranes

1 reference

12 December 2020

Interleukin-2 production by tumor cells bypasses T helper function in the generation of an antitumor response

1 reference

12 December 2020

NIH conference. New approaches to the immunotherapy of cancer using interleukin-2.

1 reference

12 December 2020

Induction of tumor antigen-specific immunity using plasmid DNA immunization in mice

1 reference

12 December 2020

Effective eradication of established murine tumors with IL-12 gene therapy using a polycistronic retroviral vector.

1 reference

12 December 2020

Protein transfer of glycosyl-phosphatidylinositol-B7-1 into tumor cell membranes: a novel approach to tumor immunotherapy

1 reference

12 December 2020

Recombinant IL-12 administration induces tumor regression in association with IFN-gamma production

1 reference

12 December 2020

Tumor rejection after direct costimulation of CD8+ T cells by B7-transfected melanoma cells

1 reference

12 December 2020

Murine interleukin-4 displays potent anti-tumor activity in vivo

1 reference

12 December 2020

Active immunization of humans with dendritic cells

1 reference

12 December 2020

High-dose recombinant interleukin 2 in the treatment of patients with disseminated cancer. Responses, treatment-related morbidity, and histologic findings

1 reference

12 December 2020

Interleukin 2 gene transfer into tumor cells abrogates tumorigenicity and induces protective immunity

1 reference

12 December 2020

Autologous human dendriphages pulsed with synthetic or natural tumor peptides elicit tumor-specific CTLs in vitro.

1 reference

12 December 2020

Rapid generation of broad T-cell immunity in humans after a single injection of mature dendritic cells.

1 reference

12 December 2020

Vaccination of melanoma patients with peptide- or tumor lysate-pulsed dendritic cells

1 reference

12 December 2020

Identifiers

DOI

10.1385/IR:29:1-3:231

1 reference

Dimensions Publication ID

10 August 2017

0 references

1 reference